B2V583 AF NFT

Endonuclease MutS2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeif2ua7blkisxo4gyej6edu2fpt4gk2u6kcdjbcvmcmgbdwnf7iz4y/metadata.json
IPFS of structure file: 
bafybeiblht4nxqyedjtdmf4t7ouo25nkv4cqu67vt6y7hi4f346sngnpg4/AF-B2V583-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x2e8Fbb947b0Bc2a2DB44100d3D43354e3aA89cEA
First NFT owner address (bech32): 
genesis1968mh9rmp0p29k6yzqxn6se4fca23882catemn
Current NFT ID #253994 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
253994
Accession (UniProt):
B2V583
Name::
Endonuclease MutS2
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V583 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V583|MUTS2_CLOBA Endonuclease MutS2 OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=mutS2 PE=3 SV=1 MNKRSLRVLEFNKVKEMLKKYAYSSSAKKLVDELVPYDNTYEINNRLEESNEALEILMKKGNPPIEGLCDIGDILQRAKKGGTLTPEQLLKVLGMLTATRRMQEFFKREDQEVSFPKLEDLAYILAPINDLEKEIERSILSEDEVSDNASTTLYNIRRSLKEKNSSVREKINSIVRSNSKYLQDSLYTIRGDRYVIPVKAEYKSSVPGLVHDQSSTGATLFIEPMGLVNLNNEIKELMLKEKAEIDRVLSALSLKVKMNAEHCESNFKILTNLDFIFSKGKYACELNAIKPMVRDDGIFNIMSGRHPLIEKDKVVPLDVVLGDEFDTLMITGPNTGGKTVTLKTVGLLHIMALSGLLIPASSNSSVSFFKEVFADIGDEQSIEQSLSTFSSHLTNIVNIMEYDNRQSLILFDELGGGTDPAEGAALAIAIIENLSSKGAKLIATTHYSELKAYALNKERVENASVEFDINTLRPTYRLLIGVPGKSNAFEISKRIGLGKEVIDCAKNYMSKENLEFEGLIRNLQEKSIIAKKDARDAKVIKDEADNLKKKYEQKLERLEKVKDKAYMDAREEAKKIVANAKDEADEILKAMRELEKLGIGSGGRQRLEEERKKLKDSLEEKEKNLYKMKENDGEVLEKVALGMEAFLPSLNQTVVVISMPDNRGEVQVEAGIMKISVKLKDLRKTKQSKVEKVKKKRELKLHFSKVENRIDLRGLDAEEACYRVDKYLDDAYMGNLGEVTIVHGKGTGILRKAINDMLKRHVHVKNYRLGGYGEGGDGATIVELK